SAN DIEGO, Oct. 25 — Accelrys and GlaxoSmithKline announced on Thursday that they have been in collaboration to produce a so-called “Hits and Leads Chemically Aware Spreadsheet” to enable GSK scientists to access, analyze, and visualize vast amounts of chemical and biological data stored in GSK’s R&D databases.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.